Bioavailability of the bis- and monodigitoxosides of digitoxigenin

Paul E Fenster, R. T. MacFarland, P. E. Graves, D. Perrier, F. I. Marcus

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pharmacokinetic behavior of digitoxigenin is affected by the number of glycosides present. This study was conducted to compare the bioavailabilities of the bis- and monodigitoxosides of digitoxigenin in man. Intravenous and oral doses of the two drugs were administered to six normal volunteers. Blood samples were collected up to 28 days after each dose, and assayed for the specific drug administered and for total radioassayable drug. Both drugs were virtually completely absorbed, based on serum concentrations of administered drug plus metabolites. However, the mean bioavailability of unchanged bisdigitoxoside was only 56.3% indicating that substantial metabolism occurred prior to entry into the systemic circulation. Monodigitoxoside was virtually completely metabolized prior to entry into the systemic circulation.

Original languageEnglish (US)
Pages (from-to)649-652
Number of pages4
JournalEuropean Journal of Clinical Pharmacology
Volume28
Issue number6
DOIs
StatePublished - Nov 1985

Fingerprint

Biological Availability
Pharmaceutical Preparations
Digitoxigenin
Glycosides
Healthy Volunteers
Pharmacokinetics
digitoxigenin monodigitoxoside
Serum

Keywords

  • biovailability
  • bisdigitoxoside
  • digitoxigenin
  • healthy volunteers
  • monodigitoxoside

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Bioavailability of the bis- and monodigitoxosides of digitoxigenin. / Fenster, Paul E; MacFarland, R. T.; Graves, P. E.; Perrier, D.; Marcus, F. I.

In: European Journal of Clinical Pharmacology, Vol. 28, No. 6, 11.1985, p. 649-652.

Research output: Contribution to journalArticle

Fenster, Paul E ; MacFarland, R. T. ; Graves, P. E. ; Perrier, D. ; Marcus, F. I. / Bioavailability of the bis- and monodigitoxosides of digitoxigenin. In: European Journal of Clinical Pharmacology. 1985 ; Vol. 28, No. 6. pp. 649-652.
@article{b3a2b419f3e44879a56f97661ea59327,
title = "Bioavailability of the bis- and monodigitoxosides of digitoxigenin",
abstract = "The pharmacokinetic behavior of digitoxigenin is affected by the number of glycosides present. This study was conducted to compare the bioavailabilities of the bis- and monodigitoxosides of digitoxigenin in man. Intravenous and oral doses of the two drugs were administered to six normal volunteers. Blood samples were collected up to 28 days after each dose, and assayed for the specific drug administered and for total radioassayable drug. Both drugs were virtually completely absorbed, based on serum concentrations of administered drug plus metabolites. However, the mean bioavailability of unchanged bisdigitoxoside was only 56.3{\%} indicating that substantial metabolism occurred prior to entry into the systemic circulation. Monodigitoxoside was virtually completely metabolized prior to entry into the systemic circulation.",
keywords = "biovailability, bisdigitoxoside, digitoxigenin, healthy volunteers, monodigitoxoside",
author = "Fenster, {Paul E} and MacFarland, {R. T.} and Graves, {P. E.} and D. Perrier and Marcus, {F. I.}",
year = "1985",
month = "11",
doi = "10.1007/BF00607909",
language = "English (US)",
volume = "28",
pages = "649--652",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Bioavailability of the bis- and monodigitoxosides of digitoxigenin

AU - Fenster, Paul E

AU - MacFarland, R. T.

AU - Graves, P. E.

AU - Perrier, D.

AU - Marcus, F. I.

PY - 1985/11

Y1 - 1985/11

N2 - The pharmacokinetic behavior of digitoxigenin is affected by the number of glycosides present. This study was conducted to compare the bioavailabilities of the bis- and monodigitoxosides of digitoxigenin in man. Intravenous and oral doses of the two drugs were administered to six normal volunteers. Blood samples were collected up to 28 days after each dose, and assayed for the specific drug administered and for total radioassayable drug. Both drugs were virtually completely absorbed, based on serum concentrations of administered drug plus metabolites. However, the mean bioavailability of unchanged bisdigitoxoside was only 56.3% indicating that substantial metabolism occurred prior to entry into the systemic circulation. Monodigitoxoside was virtually completely metabolized prior to entry into the systemic circulation.

AB - The pharmacokinetic behavior of digitoxigenin is affected by the number of glycosides present. This study was conducted to compare the bioavailabilities of the bis- and monodigitoxosides of digitoxigenin in man. Intravenous and oral doses of the two drugs were administered to six normal volunteers. Blood samples were collected up to 28 days after each dose, and assayed for the specific drug administered and for total radioassayable drug. Both drugs were virtually completely absorbed, based on serum concentrations of administered drug plus metabolites. However, the mean bioavailability of unchanged bisdigitoxoside was only 56.3% indicating that substantial metabolism occurred prior to entry into the systemic circulation. Monodigitoxoside was virtually completely metabolized prior to entry into the systemic circulation.

KW - biovailability

KW - bisdigitoxoside

KW - digitoxigenin

KW - healthy volunteers

KW - monodigitoxoside

UR - http://www.scopus.com/inward/record.url?scp=0021968634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021968634&partnerID=8YFLogxK

U2 - 10.1007/BF00607909

DO - 10.1007/BF00607909

M3 - Article

C2 - 4065189

AN - SCOPUS:0021968634

VL - 28

SP - 649

EP - 652

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 6

ER -